Sign In
Buy CNBX
$0.0002
+0 (+0%)
At Close: Jun 03, 2026
CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Short Interest Update
01:29am, Sunday, 01'st Feb 2026
CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX - Get Free Report) was the recipient of a significant growth in short interest in January. As of January 15th, there was short interest totaling 100,000 shares,
Short Interest in CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Drops By 97.5%
04:37am, Wednesday, 14'th Jan 2026
CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX - Get Free Report) was the recipient of a significant decrease in short interest in the month of December. As of December 31st, there was short interest totalin
CEO of Cannabics Pharmaceuticals, Eyal Barad, to present at Edison Open Forum: Cannabinoids 2021
09:41am, Tuesday, 19'th Oct 2021
TEL AVIV, Israel and BETHESDA, Md., Oct. 19, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, annou
Cannabics Pharmaceuticals Announces Two New Provisional Patents: Compositions and Methods For Treating Cancer
12:49pm, Monday, 18'th Oct 2021
Cannabics Pharmaceuticals Inc. (OTC:CNBX), a global leader in the development of cancer-related cannabinoid-based medicine, announced on Monday that it has filed two new provisional patent applicatio
Cannabics Pharmaceuticals Files 2 Provisional Patents On Compositions and Methods for Treating Cancer
09:05am, Monday, 18'th Oct 2021
TEL AVIV, Israel and BETHESDA, Md., Oct. 18, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, annou
Cannabics Announces New Corporate Logo, New Website and New Company Presentation
09:25am, Thursday, 30'th Sep 2021
TEL AVIV, Israel and BETHESDA, Md., Sept. 30, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine and
Gabriel Yariv, Executive Director of Cannabics Pharmaceuticals and Dr. David Sans will participate at the ICDP Summit in Boston
09:15am, Wednesday, 22'nd Sep 2021
TEL AVIV, Israel and BETHESDA, Md., Sept. 22, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, annou
Cannabics Pharmaceuticals hires Healthcare Investment Banker Dr. David Sans in New York to expand CNBX in Mental Health Diseases
09:20am, Tuesday, 21'st Sep 2021
TEL AVIV, Israel and BETHESDA, Maryland, Sept. 21, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announc
Neuropsychiatry Expert Dr. Ilya Reznik (MD) Joins Cannabics as Head of Psychedelic Inspired Medicine
08:25am, Monday, 13'th Sep 2021
TEL AVIV, Israel and BETHESDA, Md., Sept. 13, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine and
World-Renowned Melanoma Expert Joins Cannabics Pharmaceuticals' Board of Advisors
08:00am, Wednesday, 04'th Aug 2021
TEL AVIV, Israel and BETHESDA, Maryland, Aug. 4, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine,
Cannabics Pharmaceuticals Appoints a Second Independent Board Member
07:35am, Tuesday, 20'th Jul 2021
TEL AVIV, Israel and BETHESDA, Maryland, July 20, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine,
Cannabics Pharmaceuticals Announces Appointment of New Independent Board Member
08:50am, Wednesday, 07'th Jul 2021
TEL AVIV, Israel and BETHESDA, Md., July 7, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, annou
Cannabics Pharmaceuticals' Drug Candidate Exhibits 30% Tumor Volume Reduction in Mice
08:42am, Monday, 28'th Jun 2021
TEL AVIV, Israel and BETHESDA, Md., June 28, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, rele
Cannabics Pharmaceuticals to launch Drug Development Programs for Prostate Cancer and Neurodegenerative & Mental Health Diseases
08:15am, Thursday, 17'th Jun 2021
TEL AVIV, Israel and BETHESDA, Maryland, June 17, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine,
Cannabics Pharmaceuticals Launches a Breast Cancer Treatment Research Program
07:59am, Thursday, 03'rd Jun 2021
TEL AVIV, Israel and BETHESDA, Md., June 3, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, anno
